Home > Publications > Medical Specialty > Internal Medicine > Respiratory > NZ Respiratory Research Review Issue 236
NZ Respiratory Research Review Issue 236

NZ Respiratory Research Review Issue 236

In this issue:

– Mortality trends in IPF in Europe: 2013–2018

– Nerandomilast for IPF

– Bexotegrast for IPF

– Pirfenidone and lung cancer risk in IPF

– Pirfenidone in post-COVID-19 pulmonary fibrosis

– Sarcoidosis treatment patterns in the US: 2016–2022

– First-line prednisone or methotrexate for pulmonary sarcoidosis

– AI evaluation of lung function for ILD diagnosis

– Pulmonary sarcoidosis: differences in lung function change over time

– Tofacitinib vs. CNI in dermatomyositis-associated ILD

You need to be logged in to access this content.

Lutz-Beckert

Expert contributor

Professor Lutz Beckert

Lutz Beckert is the Dean and Head of Campus of the University of Otago, Christchurch. Lutz is also a Respiratory Physician at Te Whatu Ora Panui Canterbury with a clinical interest in Pulmonary Arterial Hypertension, Respiratory Physiology, and Airways Disease. Lutz has published more than 130 peer reviewed article including co-authoring the NZ Adolescent and […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.
Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court. 

It looks like you are closest to our Australia site.